Sarah Blackmore

Sarah Blackmore is an accomplished professional in the field of gene therapy and biomanufacturing, currently serving as Associate Director of Gene Therapy BDS External Manufacturing at Sarepta Therapeutics since March 2022, following a role as Senior Manager in the same department. Prior experience includes holding positions such as Viral Vector and Gene Therapy Technology Manager at Pall Biotech and Downstream Manufacturing and Process Development at Amgen. Sarah's academic background includes a Master's degree in Biotechnology from Brown University and a Bachelor of Arts in Biological Sciences from Cornell University. Research experience encompasses Alzheimer's Disease research at Massachusetts General Hospital and genetics studies on aging in C. elegans models while at Cornell University.